MINNEAPOLIS (MedPage Today) -- Combining denosumab (Prolia) with the anabolic agent teriparatide (Forteo) significantly improved bone mineral density more than did either agent alone in women at high risk of fracture, a researcher reported here. via MedPageToday.com - medical news plus CME for physicians Read More Here..
No comments:
Post a Comment